2403-88-5 | Sigma-Aldrich

GR 144053- Non-peptide antagonist of the platelet glycoprotein IIb/IIIa (GP IIb/IIIa) fibrinogen receptor

., et al., J. Leukoc. Biol., 68, 31-37 (2000). 60. Baker, J.E., et al., Mol. Cell. Biol., 21, 2393-2403 (2001). 61. Horiba, M., et al., J. Clin. Invest., 105, 489-497 (2000). 62. Qi, M., et al., J. Biol

Protein Tyrosine Phosphatases- Potential Roles in Disease

., et al., J. Leukoc. Biol., 68, 31-37 (2000). 60. Baker, J.E., et al., Mol. Cell. Biol., 21, 2393-2403 (2001). 61. Horiba, M., et al., J. Clin. Invest., 105, 489-497 (2000). 62. Qi, M., et al., J. Biol

Pellicon® Capsules with Ultracel® Membrane

1288 1627 2915 PCC030C45G 4.5 1665 2307 3972 PCC030C45L 1683 2316 3999 PCC030C45E 1857 2403 4260 Conclusion Hold-up volumes in the feed channel of Pellicon® Capsules were characterized to

Pellicon® Capsules with Ultracel® Membrane

1288 1627 2915 PCC030C45G 4.5 1665 2307 3972 PCC030C45L 1683 2316 3999 PCC030C45E 1857 2403 4260 Conclusion Hold-up volumes in the feed channel of Pellicon® Capsules were characterized to

Diabetes and Obesity

formation in vascular smooth muscle cells. Composition: 88-95% lipid; 5-12% protein. Purity: ≥95% of total lipoprotein content by electrophoresis. 5 mg Apolipoproteins and Lipoproteins (continued)